The Japanese Encephalitis (JE) vaccine market is projected to expand at a 5.2% CAGR from 2025 to 2034, driven by rising mosquito-borne disease prevalence, government-led immunization campaigns, and increased healthcare investments. JE, a viral infection transmitted by mosquitoes, primarily affects children in endemic regions across Asia and the Western Pacific. Vaccination remains the... https://www.expertmarketresearch.com/reports/japanese-encephalitis-vaccine-market